Company page

Appili Therapeutics Inc Class A

Appili Therapeutics Inc Class A, trading under the ticker APLI, is a public company based in Canada. The company has a market capitalization of approximately CAD 1.41 million. Appili focuses on developing innovative therapies to address unmet medical needs.

APLI:TSXUpdated August 7, 2026
Appili Therapeutics Inc Class A logo
Ticker
APLI:TSX
Asset type
Stock
Market cap
$944,035
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TSX
Currency
CAD